Two failed drugs in 6 months. Stock is in the tank. Leadership in disarray. Nobody trust leadership. But don’t worry, they are more focused on mandates and DE&I. We should be in good shape for the future.
TAK-721 Karma is a Biatch For Leadership
- Thread starter anonymous
- Start date
-
- Tags
- None
Yup they are really pushing the stuff that doesn’t matter
3 vax approved in a few months time. 2 pills approved in a couple months time (while already having a well established and safe generic on market). Maybe Takeda should look at bringing Budesonide to market for Covid. Looks like that will be the only way to get a Takeda product approved. Of course, Takeda would screw that up too.
I can hear SS crafting his reply: “We already knew this would happen and, while disappointing, it is the right thing to do. We were already working on a backup plan and it’s really a better investment than TAK-721 ever was - just wait. It will be great”….. blah, blah, blah, etc, etc, etc……Nothing to see here, folks…pay no attention to that man behind the curtain…..
The culture at Takeda is “don’t get fired”. That’s it. Nobody is willing to do more than the minimum. ESPECIALLY leadership. This place is too far gone to fix unless they fire Ramona and almost every division’s sales TET leaders
Don't forget Entyvio SubQ (which is already approved in EU and Canada - but for some strange reason isn't ready for the US) and Alofisel, which has also been approved in EU for quite some time. So those products are good enough for foreign populations, but not the US? Riiiiight.
The FDA either has a vendetta against Takeda or there are inept teams preparing these launches for the US market. Or perhaps it's a combination of both. I would expect global leadership to do a systemic review of these launch failures - and then hold people accountable. This is launch excellence???
Takeda’s regulatory people have an extremely long track record if ineptitude with the FDA. Imagine if Nesina was first to market like it was supposed to be….. incredible that the company cant get the drug physicians already use as standard of care for eoe approved while Biogen can get a literal dog approved. Hilarious how garbage this company is. Honestly surprised Christophe and Ramona havent been fired.
FDA is biased against Japanese company. Look who got the first DPP4 inhibitor.
Plump too.
Something upside down with R&D and regulatory
Hey! At least all the tards are vaxxed! Even though it does absolutely NOTHING
Abundantly clear now with all these highly publicized breakthroughs that vaccinations DO NOTHING to stop the spread. Over a dozen 100% vaxxed cruises returned to port last week when breakthrough cases surged. Omicron or not, vaccines have never stopped the spread, therefore it's now painfully obvious MANDATES are and have been useless!
Focus is on Gay, Race, Mandates…none of that has to do with the success of a company. Takeda has become an arm of CNN or MSNBC. And look at how they are doing with what they’ve focused on…horrible inclusion scores and horrible stock price. Here in home office, no one dares to push back. Horrible culture right now.
FDA approved eye drops from Abbvie (Who wants to put unknown substances in our eyes) but not an age old med in EOE. So either the FDA hates TAKEDA’s guts or everyone else is paying them off